Trelagliptin Succinate Cas:1029877-94-8

We are Trelagliptin Succinate CAS:1029877-94-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Description:

Product Name: Trelagliptin succinate CAS NO:1029877-94-8

 

Synonyms:

SYR-472;

(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile succinate;

 

Chemical & Physical Properties:

Appearance : White to off-white powder

Assay :≥99.0%

 

Trelagliptin Succinate, developed by Takeda, Japan, was marketed in March 2015 under the trade name Zafatek, used for the treatment of type 2 diabetes. Troxagliptin is an ultra-long-acting dipeptidyl peptidase IV (DPP-4) inhibitor by selectively and continuously inhibiting DPP-4 to control blood sugar levels. Traxagliptin is the world’s first oral once-a-week hypoglycemic drug, and similar DPP-4 inhibitors on the market need to be taken orally once a day. Zafatek’s advantages will undoubtedly provide a more convenient treatment option for diabetic patients. , It is expected to greatly improve the convenience and compliance of patients.

 

If you are interested in our products or have any questions, please feel free to contact us!

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.

 

 

 

Related Products:ent-3α-hydroxy-2α-methyl-20-norgibberella-1(10),16-diene-7,19-dioic acid 7,19-dimethyl ester manufacturer | 8-methoxycarbonyloctyl 2-acetamido-3-O-allyl-6-O-benzyl-2-deoxy-β-D-glucopyranoside supplier | 2-(4-Bromo-2-methylcarbamoyl-phenoxy)-butyric acid producer.